Richard John Rees Buys 4,712 Shares of Creo Medical Group PLC (LON:CREO) Stock

Creo Medical Group PLC (LON:CREO) insider Richard John Rees bought 4,712 shares of the company’s stock in a transaction dated Thursday, January 16th. The stock was bought at an average cost of GBX 19 ($0.23) per share, with a total value of £895.28 ($1,105.83).

Richard John Rees also recently made the following trade(s):

• On Thursday, October 24th, Richard John Rees purchased 98,000 shares of Creo Medical Group stock. The stock was bought at an average price of GBX 20 ($0.25) per share, for a total transaction of £19,600 ($24,209.49).

Creo Medical Group Stock Up 3.6 %

Shares of LON CREO opened at GBX 18 ($0.22) on Friday. Creo Medical Group PLC has a 52-week low of GBX 12 ($0.15) and a 52-week high of GBX 43 ($0.53). The company has a debt-to-equity ratio of 29.96, a quick ratio of 2.19 and a current ratio of 3.24. The business has a fifty day moving average of GBX 17.56 and a two-hundred day moving average of GBX 23.36. The stock has a market cap of £65.12 million, a PE ratio of -300.00 and a beta of 0.86.

Creo Medical Group Company Profile

Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.

The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.